Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,06 CAD | -7,69% | +9,09% | +50,00% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jason Carroll
CEO | Chief Executive Officer | - | 01-10-23 |
James Kuo
FOU | Founder | 58 | 24-09-19 |
James O’Neill
DFI | Director of Finance/CFO | 64 | 19-09-22 |
James Gilligan
PSD | President | 72 | 01-11-20 |
Chief Operating Officer | - | 23-06-22 | |
Chief Tech/Sci/R&D Officer | - | - | |
Peter Guzzo
PRN | Corporate Officer/Principal | - | 22-12-20 |
Peter Molloy
PRN | Corporate Officer/Principal | 52 | 25-09-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Kuo
FOU | Founder | 58 | 24-09-19 |
Peter Molloy
PRN | Corporate Officer/Principal | 52 | 25-09-20 |
Director/Board Member | - | 25-05-22 | |
Gage Jull
CHM | Chairman | 64 | 25-09-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 96 419 347 | 94 755 518 ( 98,27 %) | 0 | 98,27 % |
Bedrijfsgegevens
Tryp Therapeutics, Inc.
1665 Ellis Street Suite 301
V1Y 2B3, Kelowna
+833-811-8797
http://tryptherapeutics.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+50,00% | 4,23 mln. | |
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |
- Beurs
- Aandelen
- Koers TRYP
- Onderneming Tryp Therapeutics Inc.